Type I Interferon Resistance in Colorectal Cancer Cells
Author Information
Author(s): C.A. Toth, P. Thomas
Primary Institution: New England Deaconess Hospital, Harvard Medical School
Hypothesis
Is type I interferon resistance associated with a more aggressive phenotype in colorectal cancer cells?
Conclusion
The type I interferon resistant variant of the colorectal cancer cell line MIPIOI exhibits a more aggressive phenotype and higher metastatic potential compared to its parent line.
Supporting Evidence
- The resistant cell line P-MIP101 grew tumors at twice the rate of the parent line MIPIOI in vivo.
- P-MIP101 produced liver metastases at a higher frequency than MIPIOI.
- Both cell lines had similar growth rates in vitro but differed significantly in their in vivo behavior.
Takeaway
Some cancer cells can resist treatments that usually help stop their growth, making them grow faster and spread more in the body.
Methodology
The study involved culturing colorectal cancer cell lines, assessing their growth and metastatic potential in nude mice, and analyzing their response to interferons.
Limitations
The study primarily focuses on in vitro and in vivo models, which may not fully represent human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website